Key result
Purβ missense variants show ~2-fold less Acta2 promoter repressor activity than wild-type Purβ.
Why the study?
Although structural domains enabling Purβ interaction with purine-rich single-stranded DNA sequences in the Acta2 promoter have been identified, little was known about the physical and functional effects of single-nucleotide polymorphisms that alter individual amino acid residues in Purβ.
Do rare single-nucleotide polymorphic variants of Purβ alter its protein structure, ssDNA binding affinity, transcription factor interactions, and transcriptional repressor activity toward the Acta2 promoter in fibroblasts and smooth muscle cells?
Do rare single-nucleotide polymorphic variants of Purβ alter its protein structure, ssDNA binding affinity, transcription factor interactions, and transcriptional repressor activity toward the Acta2 promoter in fibroblasts and smooth muscle cells?
Rare missense variants in the Purβ transcriptional repressor impair its ability to repress the smooth muscle α-actin (Acta2) promoter by altering protein-protein interactions with co-regulatory transcription factors rather than disrupting ssDNA binding or protein stability.
Answers are grounded in this paper and cite their sources.
Purβ variants may disrupt smooth muscle gene regulation; leaves open relevance to human vascular phenotypes.
Purine-rich element-binding protein B (Purβ) inhibits myofibroblast differentiation by repressing the expression of the smooth muscle α-actin gene (Acta2). Several reports have identified the structural domains in Purβ that enable its characteristic interaction with purine-rich single-stranded DNA (ssDNA) sequences in the Acta2 promoter. However, little is known about the physical and functional effects of single-nucleotide polymorphisms that alter individual amino acid residues in Purβ. This study evaluated seven rare single amino acid variants of human PURB engineered into the homologous mouse Purβ protein. Mapping the location of variant residues on a homology model of the Purβ homodimer suggested that most of the altered residues are remote from the predicted ssDNA-binding regions of the protein. The repressor activity of each Purβ variant was assessed in transfected fibroblasts and smooth muscle cells via Acta2 promoter-reporter assays. A Q64* nonsense variant was completely inactive while missense variants exhibited repressor activity that ranged from ~1.5-fold greater to ~2-fold less than wild-type Purβ. Lower activity variants P223L and R297Q were expressed in bacteria and purified to homogeneity. Each variant was physically indistinguishable from wild-type Purβ in terms of quaternary structure and thermostability. Results of DNA and protein-binding assays indicated that the P223L and R297Q variants retained high affinity and specificity for purine-rich ssDNA sequences but differed in their interaction with other Acta2 regulatory proteins. These findings suggest that the presence of certain variant residues affects the Acta2 repressor activity of Purβ by altering its interaction with other transcription factors but not with ssDNA.
No takes yet. Share an insight, caveat, or question.
Ferris et al. (2018) studied Myofibroblast differentiation and tissue fibrosis. Engineered single-nucleotide polymorphic variants of Purβ (L46V, G215S, P223L, F274L, G282S, R297Q, and Q64) vs. Wild-type (WT) NHis-Purβ and empty pCI vector control was evaluated on Transcriptional repressor activity toward an Acta2 promoter-luciferase reporter construct (pVSMP8-Luc) (p=<0.05). Purβ missense variants G215S, P223L, and R297Q exhibited ~2-fold less Acta2 promoter repressor activity than wild-type Purβ, while the Q64 nonsense variant was completely inactive.
Synapse has enriched 10 related papers. Consider them for comparative context: